Gujarat Govt to Withdraw Dual Pricing Policy on Cardiac Stents, AiMeD Welcomes End to USFDA Bias Farhat Nasim5 April 2025 4:33 PM ISTNew Delhi: In a significant policy reversal, the Gujarat government has withdrawn a contentious dual pricing order for cardiac stents that offered...
Strides Pharma Recalls Testosterone Gel In US Market Farhat Nasim5 April 2025 1:27 PM ISTThe Chestnut Ridge-based drugmaker, a part of Bengaluru-based Strides Pharma Science, is recalling the affected lot due to the 'Presence of Benzene'.
AbbVie Lowers 2025 Earnings Forecast After USD 20 Billion Acquisition Spree Farhat Nasim5 April 2025 11:15 AM ISTAbbVie has been focusing on expanding its pipeline since its blockbuster arthritis drug, Humira, lost patent protection in 2023.
Bayer Takes Roundup Cancer Case Back to Supreme Court Farhat Nasim5 April 2025 10:45 AM ISTBayer has warned U.S. lawmakers it might halt Roundup sales to farmers, unless they can strengthen legal protection against the litigation.
Pfizer Gets CDSCO Panel Nod To study Marstacimab Dr. Divya Colin4 April 2025 6:00 PM ISTNew Delhi: The pharmaceutical major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Fake pharmacy registration racket busted, Delhi Pharmacy Council former employee, 46 others arrested Ruchika Sharma4 April 2025 5:29 PM ISTNew Delhi: In a major crackdown, the Anti-Corruption Branch (ACB) has busted a fake pharmacy registration racket and arrested a former employee...
Emcure Pharma European arm Tillomed buys strategic pharma portfolio from Manx for 19.7 million pounds Ruchika Sharma4 April 2025 4:30 PM ISTPune: Tillomed Laboratories Limited, a subsidiary of Emcure Pharmaceuticals Ltd. and a European pharma company, has entered into an Asset...
AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancer Ruchika Sharma4 April 2025 3:30 PM ISTCambridge: AstraZeneca has announced that the Company's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union...
USFDA grants nod for Amgen Uplizna as first treatment for rare immune disorder Ruchika Sharma4 April 2025 2:30 PM ISTThousand Oaks: Amgen has announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) for...
Natco Pharma Executive VP - Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API), Dr Ramesh Dandala, superannuates Ruchika Sharma4 April 2025 1:30 PM ISTTelangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer, Intellectual...
Shilpa Medicare marketing partner Amneal Pharma unveils multiple myeloma treatment Boruzu Ruchika Sharma4 April 2025 12:30 PM ISTKarnataka: Shilpa Medicare has announced that the Company's marketing partner, Amneal Pharmaceuticals, has launched BORUZU, (Bortezomib...
Novo Nordisk reshapes Executive management team Ruchika Sharma4 April 2025 11:30 AM IST Novo Nordisk HA has announced that Camilla Sylvest has decided to leave the company after a distinguished career of 28 years with the Company,...
